|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

,
* Arthritis Center of Excellence, Toronto Western Research Institute, Toronto, Canada;
Department of Immunology, University of Toronto, Toronto, Canada; and
Department of Medicine, University Health Network, Toronto, Canada
New Zealand Black (NZB) mice develop a lupus-like syndrome. Although the precise immune defects leading to autoantibody production in these mice have not been characterized, they possess a number of immunologic abnormalities suggesting that B cell tolerance may be defective. In the bone marrow, immature self-reactive B cells that have failed to edit their receptors undergo apoptosis as a consequence of Ig receptor engagement. Splenic transitional T1 B cells are recent bone marrow emigrants that retain these signaling properties, ensuring that B cells recognizing self-Ags expressed only in the periphery are deleted from the naive B cell repertoire. In this study we report that this mechanism of tolerance is defective in NZB mice. We show that NZB T1 B cells are resistant to apoptosis after IgM cross-linking in vitro. Although extensive IgM cross-linking usually leads to deletion of T1 B cells, in NZB T1 B cells we found that it prevents mitochondrial membrane damage, inhibits activation of caspase-3, and promotes cell survival. Increased survival of NZB T1 B cells was associated with aberrant up-regulation of Bcl-2 after Ig receptor engagement. We also show that there is a markedly increased proportion of NZB T1 B cells that express elevated levels of Bcl-2 in vivo and provide evidence that up-regulation of Bcl-2 follows encounter with self-Ag in vivo. Thus, we propose that aberrant cell signaling in NZB T1 B cells leads to the survival of autoreactive B cells, which predisposes NZB mice to the development of autoimmunity.
This article has been cited by other articles:
![]() |
M. Kuraoka, D. Liao, K. Yang, S. D. Allgood, M. C. Levesque, G. Kelsoe, and Y. Ueda Activation-Induced Cytidine Deaminase Expression and Activity in the Absence of Germinal Centers: Insights into Hyper-IgM Syndrome J. Immunol., September 1, 2009; 183(5): 3237 - 3248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Fletcher, N. Seach, J. J. Reiseger, T. E. Lowen, M. V. Hammett, H. S. Scott, and R. L. Boyd Reduced Thymic Aire Expression and Abnormal NF-{kappa}B2 Signaling in a Model of Systemic Autoimmunity J. Immunol., March 1, 2009; 182(5): 2690 - 2699. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Piotrowski, M. Lianeri, M. Mostowska, M. Wudarski, H. Chwalinska-Sadowska, and P. Jagodzinski Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland Lupus, February 1, 2008; 17(2): 148 - 151. [Abstract] [PDF] |
||||
![]() |
S. Rieken, A. Sassmann, S. Herroeder, B. Wallenwein, A. Moers, S. Offermanns, and N. Wettschureck G12/G13 family g proteins regulate marginal zone B cell maturation, migration, and polarization. J. Immunol., September 1, 2006; 177(5): 2985 - 2993. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Cheung, N.-H. Chang, Y.-C. Cai, G. Bonventi, R. MacLeod, and J. E. Wither Functional Interplay between Intrinsic B and T Cell Defects Leads to Amplification of Autoimmune Disease in New Zealand Black Chromosome 1 Congenic Mice J. Immunol., December 15, 2005; 175(12): 8154 - 8164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |